Concepedia

Emily Clayton

EC

8

Publications

412

Citations

8

H-Index

2019

Active since

Affiliations

Adelphi Group (United Kingdom)(Current)

University of Liverpool

Royal Lancaster Infirmary

University of Southampton

University of Oxford

Emily Clayton is an author at Adelphi Group (United Kingdom) specializing in medicine, biomedical engineering, and virology.

ORCID

Top concepts

Publications per year

2019–2024

8

Publications

8

Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study

Shelley Potter, Elizabeth J. Conroy, Ramsey I Cutress et al. · The Lancet Oncology · 2019 · 188 citations · Full text

Artificial Intelligence-Assisted Loop Mediated Isothermal Amplification (AI-LAMP) for Rapid Detection of SARS-CoV-2

Mohammed A. Rohaim, Emily Clayton, İrem Şahin et al. · Viruses · 2020 · 58 citations · Full text

, , +15

Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan

Andrea Leith, Amanda Ribbands, Jeri Kim et al. · BMC Urology · 2022 · 44 citations · Full text

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 34 citations · Full text

Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan

Andrea Leith, Jeri Kim, Amanda Ribbands et al. · Advances in Therapy · 2022 · 33 citations · Full text

Rows per page

1–5 of 8